Indivior to Pay $300 Million Settlement to Resolve Improper Marketing Allegations
- April 30, 2021
Indivior Inc. will pay $300 million to resolve allegations it falsely marketed the opioid addiction treatment drug Suboxone, which resulted in improper Medicaid payments, California Attorney General Rob Bonta announced April 27.
ARTICLE TAGS
You must be logged in to access this content.